Understanding Cannabis-Based Therapeutics in Sports Medicine
SCC Member Gretchen E. Maurer, DO, MS and colleagues examine the current research potential for cannabis in sports medicine.
Author Archive for: michellesmith
Entries by Michelle Smith
Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
Authors: Tim Curran , Hélène Devillez , Sophie L. York Williams and L. Cinnamon Bidwell Published in Journal of Cannabis Research 2020 Abstract The ratio of Δ9-tetrahydrocannabinol (THC) to cannabidiol…
Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey
Authors: Samuel Yeroushalmi, Kamaria Nelsona, Andrew Sparks, Adam Friedman Published in Complementary Therapies in Medicine September 2020 Abstract Objectives Evidence suggests that cannabinoids may provide therapeutic benefit to patients with…
Medical marijuana certification for patients with sickle cell disease: a report of a single center experience
Authors: Susanna A. Curtis, Dana Lew, Jonathan Spodick, Jeanne E. Hendrickson, Caterina P. Minniti, John D. Roberts Published in Blood Advances August 2020 Abstract More than one-third of adults with…
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)
Authors: Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri…
A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men
Authors: Hriday P. Bhambhvani BS, Alex M.Kasman MD, Genester Wilson-King MD, Michael L. Eisenberg MD Published in Sexual Medicine September 2020 Abstract Introduction Cannabis is the most commonly used drug…
Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018
Authors: Hudson Reddon, Kora DeBeck, M Eugenia Socias, Stephanie Lake, Huiru Dong, Mohammad Karamouzian, Kanna Hayashi, Thomas Kerr, M-J Milloy Published in American Journal of Public Health August 2020 Abstract…
A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol
Authors: Falone Sunda, Afolake Arowolo Published in The FASEB Journal April 2020 Abstract Cannabidiol (CBD) is considered a non-psychoactive, antioxidant, and anti-inflammatory compound derived from the Cannabis sativa plant. There…
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Authors: Gil Bar-Sela, Cohen Idan, Salvatore Campisi-Pinto, Gil M Lewitus Published in Cancers August 2020 Abstract Cannabis or its derivatives are widely used by patients with cancer to help with…
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
Authors: Viola Brugnatelli, Fabio Turco, Ulderico Freo and Gastone Zanette Published in Frontiers in Neuroscience April 2020 Introduction Irritable Bowel Syndrome (IBS) is a functional disorder characterized by abdominal pain,…
A molecular basis for the anti‐inflammatory and anti‐fibrosis properties of cannabidiol
Authors: Falone Sunda, Afolake Arowolo Published in The FASEB Journal September 2020 Abstract Cannabidiol (CBD) is considered a non‐psychoactive, antioxidant, and anti‐inflammatory compound derived from the Cannabis sativa plant. There…
The present status of artisanal cannabis for the treatment of epilepsy in the United States.
Authors: Dustin Sulak, Russell Saneto, Bonni Goldstein Published in Epilepsy & Behavior May 2017 Abstract The widespread patient use of artisanal cannabis preparations has preceded quality validation of cannabis use…